Your browser is no longer supported. Please, upgrade your browser.
BAX [NYSE]
Baxter International Inc.
IndexS&P 500 P/E36.21 EPS (ttm)2.38 Insider Own0.10% Shs Outstand500.00M Perf Week0.45%
Market Cap43.28B Forward P/E19.60 EPS next Y4.40 Insider Trans-7.60% Shs Float499.89M Perf Month2.87%
Income1.21B PEG3.24 EPS next Q1.03 Inst Own87.20% Short Float1.00% Perf Quarter5.92%
Sales12.45B P/S3.48 EPS this Y37.10% Inst Trans-0.17% Short Ratio2.08 Perf Half Y6.33%
Book/sh17.54 P/B4.92 EPS next Y21.83% ROA6.10% Target Price97.80 Perf Year8.51%
Cash/sh6.50 P/C13.28 EPS next 5Y11.17% ROE14.10% 52W Range73.12 - 88.91 Perf YTD0.51%
Dividend1.12 P/FCF44.11 EPS past 5Y24.40% ROI8.60% 52W High-2.96% Beta0.64
Dividend %1.30% Quick Ratio1.80 Sales past 5Y3.20% Gross Margin39.90% 52W Low18.00% ATR1.47
Employees50000 Current Ratio2.40 Sales Q/Q8.50% Oper. Margin12.50% RSI (14)57.98 Volatility1.70% 1.52%
OptionableYes Debt/Eq0.68 EPS Q/Q29.40% Profit Margin9.80% Rel Volume0.95 Prev Close85.99
ShortableYes LT Debt/Eq0.62 EarningsOct 28 BMO Payout43.50% Avg Volume2.41M Price86.28
Recom2.20 SMA20-0.19% SMA504.81% SMA2006.00% Volume2,290,983 Change0.34%
Jan-07-22Upgrade Morgan Stanley Equal-Weight → Overweight $86 → $110
Jan-07-22Resumed Citigroup Buy $101
Sep-13-21Upgrade Cowen Market Perform → Outperform $98
Sep-03-21Upgrade Barclays Equal Weight → Overweight $93 → $100
May-25-21Initiated Barclays Equal Weight $93
Jan-29-21Downgrade Piper Sandler Overweight → Neutral $100 → $80
Jan-06-21Downgrade UBS Buy → Neutral $95 → $85
Dec-15-20Downgrade Goldman Buy → Neutral $96 → $85
Oct-01-20Upgrade Citigroup Neutral → Buy $94
Sep-04-20Downgrade Argus Buy → Hold
Jun-24-20Initiated Oppenheimer Outperform $100
Mar-19-20Upgrade Stifel Hold → Buy $87 → $95
Mar-18-20Upgrade KeyBanc Capital Markets Sector Weight → Overweight $92
Mar-05-20Initiated Citigroup Neutral $94
Feb-13-20Initiated Goldman Buy $104
Jan-02-20Upgrade Evercore ISI In-line → Outperform $80 → $94
Dec-17-19Downgrade Morgan Stanley Overweight → Equal-Weight $90 → $88
Jun-26-19Initiated KeyBanc Capital Markets Sector Weight
Apr-08-19Downgrade Evercore ISI Outperform → In-line
Jan-02-19Upgrade Morgan Stanley Underweight → Overweight
Jan-21-22 09:38AM  
Jan-20-22 08:23AM  
Jan-19-22 11:50AM  
11:39AM  
09:40AM  
Jan-18-22 08:56AM  
08:55AM  
08:18AM  
08:16AM  
07:03AM  
Jan-17-22 08:38AM  
07:50AM  
Jan-14-22 03:00PM  
Jan-13-22 09:00AM  
Jan-07-22 11:23AM  
Jan-06-22 04:15PM  
09:45AM  
Jan-04-22 01:03PM  
Jan-02-22 06:47AM  
Dec-25-21 10:38PM  
Dec-23-21 05:38PM  
02:38PM  
Dec-17-21 10:38AM  
Dec-16-21 01:19PM  
Dec-13-21 11:38PM  
07:20PM  
04:38PM  
09:00AM  
Dec-08-21 08:30AM  
Dec-07-21 11:49AM  
11:05AM  
Dec-03-21 07:36AM  
Dec-02-21 05:48PM  
08:48AM  
Nov-27-21 06:28AM  
Nov-16-21 11:04AM  
09:00AM  
Nov-15-21 08:25AM  
Nov-11-21 09:00AM  
Nov-08-21 02:48PM  
08:30AM  
Nov-02-21 04:15PM  
Oct-28-21 04:30PM  
09:47AM  
08:35AM  
07:15AM  
Oct-22-21 08:19AM  
Oct-21-21 05:00PM  
03:03PM  
12:33AM  
Oct-13-21 04:15PM  
Oct-12-21 04:10AM  
Oct-11-21 08:50AM  
Oct-04-21 01:43PM  
07:29AM  
Oct-01-21 06:05PM  
06:46AM  
Sep-30-21 09:37AM  
Sep-27-21 04:05PM  
09:06AM  
Sep-23-21 11:24AM  
09:00AM  
Sep-09-21 08:00AM  
Sep-06-21 10:51AM  
Sep-04-21 08:36AM  
Sep-03-21 06:03PM  
12:04PM  
10:33AM  
09:57AM  
Sep-02-21 03:43PM  
01:34PM  
09:52AM  
08:41AM  
07:19AM  
07:14AM  
07:00AM  
04:03AM  
03:52AM  
Aug-30-21 01:10PM  
11:53AM  
08:16AM  
05:28AM  
01:35AM  
Aug-29-21 06:59PM  
06:40PM  
Aug-18-21 08:30AM  
Aug-13-21 06:54AM  
Aug-11-21 09:19AM  
07:00AM  
Aug-10-21 02:41PM  
09:47AM  
Aug-02-21 04:15PM  
Jul-29-21 06:45PM  
06:00PM  
04:15PM  
11:13AM  
08:45AM  
08:37AM  
08:00AM  
08:00AM  
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies. It also provides biological products and medical devices, and surgical hemostat and sealant products used in surgical procedures for hemostasis, tissue sealing, and adhesion prevention; premixed and oncology drug platforms, inhaled anesthesia and critical care products, and pharmacy compounding services; and generic injectable pharmaceuticals. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kunzler JacquelineSVP, Chief Quality OfficerJan 07Option Exercise30.952,21568,5548,341Jan 11 04:30 PM
Martin SeanSVP and General CounselNov 01Option Exercise50.7721,4501,089,01663,731Nov 03 04:06 PM
Martin SeanSVP and General CounselNov 01Sale79.5721,4501,706,70642,281Nov 03 04:06 PM
Martin SeanSVP and General CounselAug 02Option Exercise50.7719,8001,005,24661,977Aug 04 04:09 PM
Martin SeanSVP and General CounselAug 02Sale77.2619,8001,529,74842,177Aug 04 04:09 PM
Frye AndrewSVP, President, APACApr 12Sale84.7910,999932,6059,041Apr 14 04:04 PM
HELLMAN PETER SDirectorApr 05Option Exercise31.264,990155,98730,389Apr 07 06:55 PM
STROUCKEN ALBERT P LDirectorApr 05Option Exercise31.264,990155,98736,886Apr 07 06:57 PM
STROUCKEN ALBERT P LDirectorApr 05Sale84.564,990421,95431,896Apr 07 06:57 PM
HELLMAN PETER SDirectorApr 05Sale84.564,990421,95425,399Apr 07 06:55 PM